Hannah Wastyk

Co-Founder & CEO at Interface Biosciences

Speaker

Hannah's received her PhD in Bioengineering from Stanford in 2021. She worked in Justin Sonnenburg's lab, studying the intersection of the microbiome and immune system where she was co-first author on a paper in Cell that was also covered by the New York Times. She is currently co-founder and CEO of Interface Biosciences, a VC-backed biotech company focused on leveraging AI and metabolomics to treat autoimmune and inflammatory disease.